About hemophilia B
Hemophilia B, also called the Christmas disease, is a blood coagulation disorder due to the deficiency or improper function of factor IX. It is inherited in an X-linked recessive pattern. This disorder is more prevalent in males than in females. Factor replacement therapies, mainly recombinant, are used in the treatment.

Technavio’s analysts forecast the global hemophilia B market to grow posting a CAGR of 4.18% over the period 2014-2019.

[Covered in this report]
The report includes the present scenario and the growth prospects of the global hemophilia B market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of hemophilia B.

Technavio’s report, Global Hemophilia B Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation and landscape. The report includes a discussion of the key vendors operating in this market.

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

第Ⅸ因子欠乏症治療の世界市場2017-2021 IRTNTR12153 / Technavio / 2017年3月7日 / 当調査レポートでは、第Ⅸ因子欠乏症治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、第Ⅸ因子欠乏症治療の世界市場規模及び予測、種類別分析、市場シェア、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Factor IX Deficiency Treatment The global factor IX deficiency treatment market is characterized by the presence of various therapeutic products provided by some of the top vendors such as Shire, CSL Behring, Novo Nordisk, Biogen, and Pfizer. The adoption rate of therapeutics has undergone a paradigm shift toward the introduction of gene therapy, which will lead to the development of new products. However, the low penetration rate of recombinant therapy in developing countries is the current challenge in the market. This low penetration rate in developing countries is due to the higher cost of recombinant drugs, limited disease knowledge,...

第VIII因子欠乏症治療の世界市場2017-2021 IRTNTR12140 / Technavio / 2017年3月6日 / 当調査レポートでは、第VIII因子欠乏症治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、第VIII因子欠乏症治療の世界市場規模及び予測、種類別分析、市場シェア、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Factor VIII Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor. Technavio’s analysts...

血友病治療薬の世界市場2016-2020 IRTNTR10470 / Technavio / 2016年10月19日 / 当調査レポートでは、血友病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、血友病治療薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Hemophilia Hemophilia is an X-linked genetic disorder that results in excessive blood loss during an injury, causing fatigue or even death. The disorder is more common in males and affects roughly 400,000 people globally every year. Hemophilia A is the more common form of this disorder, while hemophilia B is the rare form of hemophilia. To mitigate this disorder, plasma-derived clotting factors or recombinant clotting factors have been developed and are administered to the affected individual. The therapy is usually done in two ways: short acting therapeutic and long-acting therapeutic. Technavio’s analysts forecast the global hemophilia drugs market to...

血友病A治療薬の世界市場2015-2019 IRTNTR7382 / Technavio / 2015年9月30日 / 当調査レポートでは、血友病A治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、血友病A治療薬の世界市場規模及び予測、種類別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About hemophilia A Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of...

子宮頸がん治療薬の世界市場2015-2019 IRTNTR7066 / Technavio / 2015年9月9日 / 当調査レポートでは、子宮頸がん治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、子宮頸がん治療薬の世界市場規模及び予測、種類別分析、用途別分析、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the infection of HPV. There are no signs and symptoms to identify the early stages of cervical cancer, but it can be identified through regular check-ups. Vaginal bleeding and pelvic pain are usually observed as signs and...

ヒトインスリンの世界市場2015-2019 IRTNTR6990 / Technavio / 2015年8月12日 / 当調査レポートでは、ヒトインスリンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、ヒトインスリンの世界市場規模及び予測、種類別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About diabetes Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1...

欧州のインシュリン市場2015-2019 IRTNTR6809 / Technavio / 2015年7月29日 / 当調査レポートでは、欧州のインシュリン市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、欧州のインシュリン市場規模及び予測、種類別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About insulin Insulin is a hormone produced by the beta cells of the pancreas; insulin has a key role in regulating the blood glucose levels. It regulates the metabolism of glucose and other nutrients in the body. Insulin permits the body to utilize sugar (glucose) from carbohydrates in the food for energy or to store glucose for future use. The beta cells of the pancreas of people with type 1 diabetes do not produce sufficient insulin to regulate blood glucose level; therefore, they need to intake insulin daily. On the other hand, people with type 2 diabetes or gestational diabetes...

ゴーシェ病治療薬の世界市場2015-2019 IRTNTR5483 / Technavio / 2015年3月18日 / 当調査レポートでは、ゴーシェ病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、ゴーシェ病治療薬の世界市場規模及び予測、種類別分析、投与経路（ROA）別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Gaucher Disease Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally. Some people may have no symptoms of this disease, while some experience severe complications. Some of the...

ヒト成長ホルモン（HGH）の世界市場2015-2019 IRTNTR4664 / Technavio / 2014年11月26日 / 当調査レポートでは、ヒト成長ホルモン（HGH）の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、ヒト成長ホルモン（HGH）の世界市場規模及び予測、市場シェア、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Human Growth Hormones Growth hormone is a proteinaceous hormone consisting of 191 amino acid residues and is secreted by the anterior part of the pituitary gland. In children and adolescents, growth hormones are produced and secreted in high levels and promote linear growth. However, as an individual reaches the adult stage, its level starts declining and primarily perform anabolic functions. The direct activity of a human growth hormone, exerted via its interaction with the human growth hormone receptor, includes metabolic and anti-insulin activities. TechNavio's analysts forecast the Global Human Growth Hormone market to grow at a CAGR of 4.22...

世界のヘモフィリア市場：Global Hemophilia Market 2014-2018 IRTNTR2939 / Technavio / 2013年11月15日 / ...TechNavio's analysts forecast the Global Hemophilia market to grow at a CAGR of 6.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the development of new hemophilia therapeutics. The Global Hemophilia market has also been witnessing the increase in technological innovations. However, the high cost of hemophilia therapeutics could pose a challenge to the growth of this market. TechNavio's report, the Global Hemophilia Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also...